Ampio Pharma (AMPE) Founder, CEO Extend Lock-Up Agreements

Ampio Pharmaceuticals, Inc. (Nasdaq: AMPE), reports that Dr. David Bar-Or, Ampio's Founder, Chief Scientific Officer and largest shareholder, and Michael Macaluso, Ampio's CEO, Chairman and Lead Investor, have extended their July 15th 2012 lock-up agreement until January of 2013. This extended lockup encompasses more than two-thirds of the company's shares owned by executives, management and directors.

---

Serious News for Serious Traders! Try StreetInsider.com Premium Free!

---

You May Also Be Interested In

• Buy this primary AI beneficiary heading into the analyst day this month: Citi
• Barclays sees a compelling investment case for this EU utility stock
• This stock offers 'resilient growth at a discount' – TD Cowen